Recruiting
Pulmonary tuberculosis
RecruitingStudy of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France
Registered drugNo placebo
Study of bedaquiline, pretomanid, linezolid and moxifloxacin combination treatment for patients with multidrug-resistant tuberculosis in France
Registered drugNo placebo
- Disease:Pulmonary tuberculosis
- Substances:BedaquilineClofazimine+3
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Bedaquiline
